MedPath
TGA Approval

SCENESSE afamelanotide (as acetate) 16 mg implant vial (327947)

327947

SCENESSE afamelanotide (as acetate) 16 mg implant vial

Clinuvel Pharmaceuticals Ltd

November 18, 2020

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/f653e44b6daad39ad049e9f16ebb1d51.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/56719e002babaa8de8298c43984bb550.pdf

Active Ingredients

afamelanotide acetate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.